Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
2000 1
2001 1
2004 4
2005 4
2006 2
2007 4
2008 2
2009 2
2010 3
2011 2
2012 3
2013 1
2014 3
2015 3
2016 5
2017 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

38 results
Results by year
Filters applied: . Clear all
Page 1
HSP90 supports tumor growth and angiogenesis through PRKD2 protein stabilization.
Azoitei N, Diepold K, Brunner C, Rouhi A, Genze F, Becher A, Kestler H, van Lint J, Chiosis G, Koren J 3rd, Fröhling S, Scholl C, Seufferlein T. Azoitei N, et al. Among authors: genze f. Cancer Res. 2014 Dec 1;74(23):7125-36. doi: 10.1158/0008-5472.CAN-14-1017. Epub 2014 Oct 8. Cancer Res. 2014. PMID: 25297628 Free PMC article.
Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin/nodal-dependent induction of stemness.
Perkhofer L, Walter K, Costa IG, Carrasco MC, Eiseler T, Hafner S, Genze F, Zenke M, Bergmann W, Illing A, Hohwieler M, Köhntop R, Lin Q, Holzmann KH, Seufferlein T, Wagner M, Liebau S, Hermann PC, Kleger A, Müller M. Perkhofer L, et al. Among authors: genze f. Stem Cell Res. 2016 Sep;17(2):367-378. doi: 10.1016/j.scr.2016.08.007. Epub 2016 Aug 10. Stem Cell Res. 2016. PMID: 27632063 Free article.
Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33.
Azoitei N, Hoffmann CM, Ellegast JM, Ball CR, Obermayer K, Gößele U, Koch B, Faber K, Genze F, Schrader M, Kestler HA, Döhner H, Chiosis G, Glimm H, Fröhling S, Scholl C. Azoitei N, et al. Among authors: genze f. J Exp Med. 2012 Apr 9;209(4):697-711. doi: 10.1084/jem.20111910. Epub 2012 Mar 26. J Exp Med. 2012. PMID: 22451720 Free PMC article.
Baseline MAPK signaling activity confers intrinsic radioresistance to KRAS-mutant colorectal carcinoma cells by rapid upregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K).
Eder S, Arndt A, Lamkowski A, Daskalaki W, Rump A, Priller M, Genze F, Wardelmann E, Port M, Steinestel K. Eder S, et al. Among authors: genze f. Cancer Lett. 2017 Jan 28;385:160-167. doi: 10.1016/j.canlet.2016.10.027. Epub 2016 Oct 25. Cancer Lett. 2017. PMID: 27793696
Protein kinase D2 is a novel regulator of glioblastoma growth and tumor formation.
Azoitei N, Kleger A, Schoo N, Thal DR, Brunner C, Pusapati GV, Filatova A, Genze F, Möller P, Acker T, Kuefer R, Van Lint J, Baust H, Adler G, Seufferlein T. Azoitei N, et al. Among authors: genze f. Neuro Oncol. 2011 Jul;13(7):710-24. doi: 10.1093/neuonc/nor084. Neuro Oncol. 2011. PMID: 21727210 Free PMC article.
38 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page